These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 10519417

  • 1. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
    de La Coste A, Mignon A, Fabre M, Gilbert E, Porteu A, Van Dyke T, Kahn A, Perret C.
    Cancer Res; 1999 Oct 01; 59(19):5017-22. PubMed ID: 10519417
    [Abstract] [Full Text] [Related]

  • 2. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
    Christensen JG, Goldsworthy TL, Cattley RC.
    Mol Carcinog; 1999 Aug 01; 25(4):273-84. PubMed ID: 10449034
    [Abstract] [Full Text] [Related]

  • 3. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS.
    Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693
    [Abstract] [Full Text] [Related]

  • 4. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 5. Implication of Bcl-2 family genes in basal and D-amphetamine-induced apoptosis in preneoplastic and neoplastic rat liver lesions.
    De Miglio MR, Muroni MR, Simile MM, Calvisi DF, Tolu P, Deiana L, Carru A, Bonelli G, Feo F, Pascale RM.
    Hepatology; 2000 Apr 25; 31(4):956-65. PubMed ID: 10733553
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
    Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, Xing L.
    Arthritis Rheum; 2005 Sep 25; 52(9):2708-18. PubMed ID: 16142752
    [Abstract] [Full Text] [Related]

  • 7. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF, Factor VM, Loi R, Thorgeirsson SS.
    Cancer Res; 2001 Mar 01; 61(5):2085-91. PubMed ID: 11280770
    [Abstract] [Full Text] [Related]

  • 8. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME, Pierce RH, Fausto N.
    Cancer Res; 2001 Jan 15; 61(2):594-601. PubMed ID: 11212255
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R, Herzer U, Schenkel J, Weiher H.
    Oncogene; 1997 Oct 09; 15(15):1787-95. PubMed ID: 9362445
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice.
    McCall TD, Pedone CA, Fults DW.
    Cancer Res; 2007 Jun 01; 67(11):5179-85. PubMed ID: 17545597
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
    Liu P, Terradillos O, Renard CA, Feldmann G, Buendia MA, Bernuau D.
    Hepatology; 1997 Apr 01; 25(4):874-83. PubMed ID: 9096591
    [Abstract] [Full Text] [Related]

  • 14. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53.
    Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S.
    Clin Immunol; 1999 Nov 01; 93(2):152-61. PubMed ID: 10527691
    [Abstract] [Full Text] [Related]

  • 15. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
    Ebinuma H, Saito H, Kosuga M, Wakabayashi K, Saito Y, Takagi T, Nakamoto N, Okuyama T, Ishii H.
    J Cell Physiol; 2001 Jul 01; 188(1):56-66. PubMed ID: 11382922
    [Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53.
    Vrana JA, Decker RH, Johnson CR, Wang Z, Jarvis WD, Richon VM, Ehinger M, Fisher PB, Grant S.
    Oncogene; 1999 Nov 25; 18(50):7016-25. PubMed ID: 10597302
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
    Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ.
    Exp Cell Res; 1995 Apr 25; 217(2):240-7. PubMed ID: 7698223
    [Abstract] [Full Text] [Related]

  • 19. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
    Linden M, Kirchhof N, Kvitrud M, Van Ness B.
    Leuk Res; 2005 Apr 25; 29(4):435-44. PubMed ID: 15725478
    [Abstract] [Full Text] [Related]

  • 20. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
    Luke JJ, Van De Wetering CI, Knudson CM.
    Cell Death Differ; 2003 Jun 25; 10(6):740-8. PubMed ID: 12761582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.